Biotechnology
Compare Stocks
2 / 10Stock Comparison
ARMP vs SIGA
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
ARMP vs SIGA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
| Market Cap | $304M | $344M |
| Revenue (TTM) | $5M | $94M |
| Net Income (TTM) | $-174M | $-4.04T |
| Gross Margin | 68.8% | 61.8% |
| Operating Margin | -6.4% | 27.7% |
| Forward P/E | — | 2.8x |
| Total Debt | $288M | $595K |
| Cash & Equiv. | $9M | $155M |
ARMP vs SIGA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Armata Pharmaceutic… (ARMP) | 100 | 223.1 | +123.1% |
| SIGA Technologies, … (SIGA) | 100 | 80.1 | -19.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ARMP vs SIGA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ARMP carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth -5.2%, EPS growth -8.2%, 3Y rev CAGR -3.8%
- -5.2% revenue growth vs SIGA's -31.8%
- -35.4% margin vs SIGA's -43K%
SIGA is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 4 yrs, beta 1.09, yield 12.5%
- 7.7% 10Y total return vs ARMP's -97.6%
- Lower volatility, beta 1.09, Low D/E 0.3%, current ratio 11.83x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -5.2% revenue growth vs SIGA's -31.8% | |
| Quality / Margins | -35.4% margin vs SIGA's -43K% | |
| Stability / Safety | Beta 1.09 vs ARMP's 1.24 | |
| Dividends | 12.5% yield; 4-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +5.1% vs SIGA's -0.7% | |
| Efficiency (ROA) | -7.4% ROA vs ARMP's -207.9%, ROIC 33.7% vs -36.0% |
ARMP vs SIGA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ARMP vs SIGA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SIGA leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
SIGA is the larger business by revenue, generating $94M annually — 19.1x ARMP's $5M. ARMP is the more profitable business, keeping -35.4% of every revenue dollar as net income compared to SIGA's -43117.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $5M | $94M |
| EBITDAEarnings before interest/tax | -$30M | $26M |
| Net IncomeAfter-tax profit | -$174M | -$4.04T |
| Free Cash FlowCash after capex | -$26M | $27M |
| Gross MarginGross profit ÷ Revenue | +68.8% | +61.8% |
| Operating MarginEBIT ÷ Revenue | -6.4% | +27.7% |
| Net MarginNet income ÷ Revenue | -35.4% | -43117.4% |
| FCF MarginFCF ÷ Revenue | -5.4% | +29.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -12.1% | -11.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -79.0% | — |
Valuation Metrics
Evenly matched — ARMP and SIGA each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $304M | $344M |
| Enterprise ValueMkt cap + debt − cash | $583M | $190M |
| Trailing P/EPrice ÷ TTM EPS | -1.73x | 14.55x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 2.82x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 7.81x |
| Price / SalesMarket cap ÷ Revenue | 62.00x | 3.64x |
| Price / BookPrice ÷ Book value/share | — | 1.73x |
| Price / FCFMarket cap ÷ FCF | — | 7.98x |
Profitability & Efficiency
SIGA leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), SIGA scores 5/9 vs ARMP's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | -10.7% |
| ROA (TTM)Return on assets | -2.1% | -7.4% |
| ROICReturn on invested capital | -36.0% | +33.7% |
| ROCEReturn on capital employed | -58.8% | +11.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | — | 0.00x |
| Net DebtTotal debt minus cash | $279M | -$154M |
| Cash & Equiv.Liquid assets | $9M | $155M |
| Total DebtShort + long-term debt | $288M | $595,169 |
| Interest CoverageEBIT ÷ Interest expense | -1.88x | — |
Total Returns (Dividends Reinvested)
ARMP leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARMP five years ago would be worth $20,244 today (with dividends reinvested), compared to $10,791 for SIGA. Over the past 12 months, ARMP leads with a +510.3% total return vs SIGA's -0.7%. The 3-year compound annual growth rate (CAGR) favors ARMP at 83.7% vs SIGA's 7.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +26.5% | -13.9% |
| 1-Year ReturnPast 12 months | +510.3% | -0.7% |
| 3-Year ReturnCumulative with dividends | +519.4% | +23.5% |
| 5-Year ReturnCumulative with dividends | +102.4% | +7.9% |
| 10-Year ReturnCumulative with dividends | -97.6% | +772.1% |
| CAGR (3Y)Annualised 3-year return | +83.7% | +7.3% |
Risk & Volatility
Evenly matched — ARMP and SIGA each lead in 1 of 2 comparable metrics.
Risk & Volatility
SIGA is the less volatile stock with a 1.09 beta — it tends to amplify market swings less than ARMP's 1.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.24x | 1.09x |
| 52-Week HighHighest price in past year | $16.34 | $9.62 |
| 52-Week LowLowest price in past year | $1.17 | $4.29 |
| % of 52W HighCurrent price vs 52-week peak | +50.8% | +49.9% |
| RSI (14)Momentum oscillator 0–100 | 42.0 | 48.5 |
| Avg Volume (50D)Average daily shares traded | 50K | 703K |
Analyst Outlook
SIGA leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates ARMP as "Buy" and SIGA as "Buy". SIGA is the only dividend payer here at 12.54% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $15.00 | — |
| # AnalystsCovering analysts | 4 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +12.5% |
| Dividend StreakConsecutive years of raises | 0 | 4 |
| Dividend / ShareAnnual DPS | — | $0.60 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
SIGA leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARMP leads in 1 (Total Returns). 2 tied.
ARMP vs SIGA: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ARMP or SIGA a better buy right now?
For growth investors, Armata Pharmaceuticals, Inc.
(ARMP) is the stronger pick with -5. 2% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 5x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate Armata Pharmaceuticals, Inc. (ARMP) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ARMP or SIGA?
Over the past 5 years, Armata Pharmaceuticals, Inc.
(ARMP) delivered a total return of +102. 4%, compared to +7. 9% for SIGA Technologies, Inc. (SIGA). Over 10 years, the gap is even starker: SIGA returned +772. 1% versus ARMP's -97. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ARMP or SIGA?
By beta (market sensitivity over 5 years), SIGA Technologies, Inc.
(SIGA) is the lower-risk stock at 1. 09β versus Armata Pharmaceuticals, Inc. 's 1. 24β — meaning ARMP is approximately 14% more volatile than SIGA relative to the S&P 500.
04Which is growing faster — ARMP or SIGA?
By revenue growth (latest reported year), Armata Pharmaceuticals, Inc.
(ARMP) is pulling ahead at -5. 2% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: SIGA Technologies, Inc. grew EPS -60. 2% year-over-year, compared to -817. 6% for Armata Pharmaceuticals, Inc.. Over a 3-year CAGR, ARMP leads at -3. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ARMP or SIGA?
SIGA Technologies, Inc.
(SIGA) is the more profitable company, earning 24. 6% net margin versus -35. 4% for Armata Pharmaceuticals, Inc. — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus -636. 7% for ARMP. At the gross margin level — before operating expenses — ARMP leads at 68. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ARMP or SIGA?
In this comparison, SIGA (12.
5% yield) pays a dividend. ARMP does not pay a meaningful dividend and should not be held primarily for income.
07Is ARMP or SIGA better for a retirement portfolio?
For long-horizon retirement investors, SIGA Technologies, Inc.
(SIGA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 09), 12. 5% yield, +772. 1% 10Y return). Both have compounded well over 10 years (SIGA: +772. 1%, ARMP: -97. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ARMP and SIGA?
Both stocks operate in the null sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ARMP is a small-cap quality compounder stock; SIGA is a small-cap deep-value stock. SIGA pays a dividend while ARMP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.